Skip to main content

Table 5 Statistical analysis of proposed and reported methods for MZH and PYH in different pharmaceutical formulations

From: Simultaneous analysis of two drugs used as supportive treatment for COVID-19: comparative statistical studies and analytical ecological appraisal

Drug

Method

Navoproxin plus® tablets

Vomidoxine B6® tablets

Dizirest B6® tablets

Mean

SD

n

V

t-testa

F-valuea

Mean

SD

n

V

t-testa

F-valuea

Mean

SD

n

V

t-testa

F-valuea

MZH

RSM

99.73

0.88

5

0.78

1.97

2.70

100.05

0.73

5

0.53

1.89

1.61

99.91

1.01

5

1.02

0.24

1.16

IDW

99.58

1.07

5

1.16

1.43

3.99

99.87

1.22

5

1.48

1.19

1.72

99.66

1.03

5

1.06

0.61

1.12

FSD

99.06

0.83

5

0.69

0.55

2.39

99.15

1.27

5

1.61

0.14

1.86

99.51

0.90

5

0.81

0.89

1.46

Reported method [9]

98.81

0.54

5

0.29

  

99.05

0.93

5

0.86

  

100.07

1.09

5

1.18

  

PYH

Direct

100.14

0.69

5

0.48

0.68

1.84

100.63

0.61

5

0.37

0.81

1.23

101.06

0.79

5

0.62

1.64

 1.44

Reported method [9]

100.50

0.94

5

0.89

  

100.93

0.55

5

0.30

  

100.15

0.95

5

 0.90

  
  1. aTheoretical of t (2.306) and F (6.39) values at p = 0.05